Cite

HARVARD Citation

    Wu, Z. et al. (2022). PH/enzyme dual sensitive and nucleus-targeting dendrimer nanoparticles to enhance the antitumour activity of doxorubicin. Pharmaceutical development and technology. pp. 357-371. [Online]. 
  
Back to record